Expansion Sees Q Chip Move to New Facility
Q Chip Ltd has officially opened its new corporate headquarters and R&D facility in Cardiff. The expansion into new headquarters marks a significant step in the steady expansion Q Chip has experienced since its foundation, according to the company.

Q Chip Ltd
In summer 2007 Q Chip successfully completed a funding round which saw it raise in excess of £2 million from existing and new shareholders. This investment is being used to expand the product range of ReaX™ encapsulated PCR reagents, Biologix™ microspheres for peptide delivery and cell encapsulation, as well as Q Chip’s proprietary MicroPlant™ microfluidic device
Commenting on the move to the new facility Executive Chairman Ken Powell stated “the management and staff of Q Chip have consistently hit all the milestones set for it by the Board and shareholders. This is a true testimony to the quality of the team. After the successful completion of a major funding round last year I believe the expansion into new headquarters provides further evidence of the momentum behind the Company and the market appetite for its products.”
Other news from the department business & finance
These products might interest you

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer
Millipore Acquires NovAseptic AB: Broadens Offering to Biotech and Pharmaceutical Industry
Evotec and Celgene collaborate in drug discovery for neurogenerative diseases
Evotec and Roche Form Global Alliance to Jointly Discover Novel Drugs

Oral vaccine instead of injections? - Exotic workers help with mRNA vaccination through the stomach
Learning how the brain takes out its trash
Newly discovered plant enzyme could lead to more efficient ethanol production from cellulose

Multifunctional catalyst for poison-resistant hydrogen fuel cells
Biotage acquires ATDBio - Biotage strengthens its position in DNA and RNA Oligonucleotide synthesis and purification
Graffinity and Elan launch fragment-based drug discovery collaboration

Q1 Results: Merck Benefits from Global Diversification in a Challenging Environment - Medium-term structural growth drivers intact
